Academic Journal
View in EDS

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer

Bibliographic Details
Title: The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
Authors: Suosu Wei, Yanrong Hao, Xiaofeng Dong, Junzhang Huang, Kai Huang, Yujie Xie, Hongjun Liu, Chunyu Wei, Jinan Xu, Wei Huang, Lingguang Dong, Jianrong Yang
Source: Frontiers in Endocrinology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
Subject Terms: MAFLD, cancer, metabolic dysfunction, fatty liver disease, incidence rate, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
More Details: BackgroundThe associations between metabolic dysfunction-associated fatty liver disease (MAFLD) and cancer development, especially extrahepatic cancers, are unknown. The aims of the current study were to investigate the cancer incidence rates of MAFLD and analyze the associations between MAFLD and the development of cancers.MethodsThis historical cohort study included participants who underwent ultrasonographic detection of hepatic steatosis at a tertiary hospital in China from January 2013 to October 2021. MAFLD was diagnosed in accordance with The International Expert Consensus Statement. Cox proportional hazards regression modeling was used to assess the associations between MAFLD and the development of cancers.ResultsOf the 47,801 participants, 16,093 (33.7%) had MAFLD. During the total follow-up of 175,137 person-years (median 3.3 years), the cancer incidence rate in the MAFLD group was higher than that in the non-MAFLD group [473.5 vs. 255.1 per 100,000 person-years; incidence rate ratio 1.86; 95% confidence interval (CI) 1.57–2.19]. After adjustment for age, gender, smoking status, and alcohol status, MAFLD was moderately associated with cancers of the female reproductive system/organs (labium, uterus, cervix, and ovary) [hazard ratio (HR) 2.24; 95% CI 1.09–4.60], thyroid (HR 3.64; 95% CI 1.82–7.30), and bladder (HR 4.19; 95% CI 1.15–15.27) in the total study cohort.ConclusionMAFLD was associated with the development of cancers of the female reproductive system/organs (labium, uterus, cervix, and ovary), thyroid, and bladder in the total study cohort.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-2392
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2023.985858/full; https://doaj.org/toc/1664-2392
DOI: 10.3389/fendo.2023.985858
Access URL: https://doaj.org/article/2c13482d18b2454a86ec1f170b95178b
Accession Number: edsdoj.2c13482d18b2454a86ec1f170b95178b
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16642392&ISBN=&volume=14&issue=&date=20230201&spage=&pages=&title=Frontiers in Endocrinology&atitle=The%20relationship%20between%20metabolic%20dysfunction-associated%20fatty%20liver%20disease%20and%20the%20incidence%20rate%20of%20extrahepatic%20cancer&aulast=Suosu%20Wei&id=DOI:10.3389/fendo.2023.985858
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/2c13482d18b2454a86ec1f170b95178b
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.2c13482d18b2454a86ec1f170b95178b
RelevancyScore: 961
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 960.989685058594
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Suosu+Wei%22">Suosu Wei</searchLink><br /><searchLink fieldCode="AR" term="%22Yanrong+Hao%22">Yanrong Hao</searchLink><br /><searchLink fieldCode="AR" term="%22Xiaofeng+Dong%22">Xiaofeng Dong</searchLink><br /><searchLink fieldCode="AR" term="%22Junzhang+Huang%22">Junzhang Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Kai+Huang%22">Kai Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Yujie+Xie%22">Yujie Xie</searchLink><br /><searchLink fieldCode="AR" term="%22Hongjun+Liu%22">Hongjun Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Chunyu+Wei%22">Chunyu Wei</searchLink><br /><searchLink fieldCode="AR" term="%22Jinan+Xu%22">Jinan Xu</searchLink><br /><searchLink fieldCode="AR" term="%22Wei+Huang%22">Wei Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Lingguang+Dong%22">Lingguang Dong</searchLink><br /><searchLink fieldCode="AR" term="%22Jianrong+Yang%22">Jianrong Yang</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Endocrinology, Vol 14 (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Diseases of the endocrine glands. Clinical endocrinology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MAFLD%22">MAFLD</searchLink><br /><searchLink fieldCode="DE" term="%22cancer%22">cancer</searchLink><br /><searchLink fieldCode="DE" term="%22metabolic+dysfunction%22">metabolic dysfunction</searchLink><br /><searchLink fieldCode="DE" term="%22fatty+liver+disease%22">fatty liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22incidence+rate%22">incidence rate</searchLink><br /><searchLink fieldCode="DE" term="%22Diseases+of+the+endocrine+glands%2E+Clinical+endocrinology%22">Diseases of the endocrine glands. Clinical endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22RC648-665%22">RC648-665</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: BackgroundThe associations between metabolic dysfunction-associated fatty liver disease (MAFLD) and cancer development, especially extrahepatic cancers, are unknown. The aims of the current study were to investigate the cancer incidence rates of MAFLD and analyze the associations between MAFLD and the development of cancers.MethodsThis historical cohort study included participants who underwent ultrasonographic detection of hepatic steatosis at a tertiary hospital in China from January 2013 to October 2021. MAFLD was diagnosed in accordance with The International Expert Consensus Statement. Cox proportional hazards regression modeling was used to assess the associations between MAFLD and the development of cancers.ResultsOf the 47,801 participants, 16,093 (33.7%) had MAFLD. During the total follow-up of 175,137 person-years (median 3.3 years), the cancer incidence rate in the MAFLD group was higher than that in the non-MAFLD group [473.5 vs. 255.1 per 100,000 person-years; incidence rate ratio 1.86; 95% confidence interval (CI) 1.57–2.19]. After adjustment for age, gender, smoking status, and alcohol status, MAFLD was moderately associated with cancers of the female reproductive system/organs (labium, uterus, cervix, and ovary) [hazard ratio (HR) 2.24; 95% CI 1.09–4.60], thyroid (HR 3.64; 95% CI 1.82–7.30), and bladder (HR 4.19; 95% CI 1.15–15.27) in the total study cohort.ConclusionMAFLD was associated with the development of cancers of the female reproductive system/organs (labium, uterus, cervix, and ovary), thyroid, and bladder in the total study cohort.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1664-2392
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fendo.2023.985858/full; https://doaj.org/toc/1664-2392
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fendo.2023.985858
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/2c13482d18b2454a86ec1f170b95178b" linkWindow="_blank">https://doaj.org/article/2c13482d18b2454a86ec1f170b95178b</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.2c13482d18b2454a86ec1f170b95178b
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2c13482d18b2454a86ec1f170b95178b
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2023.985858
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: MAFLD
        Type: general
      – SubjectFull: cancer
        Type: general
      – SubjectFull: metabolic dysfunction
        Type: general
      – SubjectFull: fatty liver disease
        Type: general
      – SubjectFull: incidence rate
        Type: general
      – SubjectFull: Diseases of the endocrine glands. Clinical endocrinology
        Type: general
      – SubjectFull: RC648-665
        Type: general
    Titles:
      – TitleFull: The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Suosu Wei
      – PersonEntity:
          Name:
            NameFull: Yanrong Hao
      – PersonEntity:
          Name:
            NameFull: Xiaofeng Dong
      – PersonEntity:
          Name:
            NameFull: Junzhang Huang
      – PersonEntity:
          Name:
            NameFull: Kai Huang
      – PersonEntity:
          Name:
            NameFull: Yujie Xie
      – PersonEntity:
          Name:
            NameFull: Hongjun Liu
      – PersonEntity:
          Name:
            NameFull: Chunyu Wei
      – PersonEntity:
          Name:
            NameFull: Jinan Xu
      – PersonEntity:
          Name:
            NameFull: Wei Huang
      – PersonEntity:
          Name:
            NameFull: Lingguang Dong
      – PersonEntity:
          Name:
            NameFull: Jianrong Yang
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 16642392
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in Endocrinology
              Type: main
ResultId 1